Concepedia

Matthew D. McReynolds

MD

7

Publications

599

Citations

7

H-Index

2001

Active since

Affiliations

University of Kansas(Current)

Pfizer (United States)

Matthew D. McReynolds is an author at University of Kansas specializing in cell signaling, tumor microenvironment, and cancer research.

Top concepts

Publications per year

2001–2017

7

Publications

7

Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1

Mark E. Schnute, Matthew D. McReynolds, Tom Kasten et al. · Biochemical Journal · 2012 · 274 citations

, , +20

(+)-Saxitoxin:  A First and Second Generation Stereoselective Synthesis

James J. Fleming, Matthew D. McReynolds, J. Du Bois · Journal of the American Chemical Society · 2007 · 152 citations

Multivalent Activation in Temporary Phosphate Tethers:  A New Tether for Small Molecule Synthesis

A. Whitehead, Matthew D. McReynolds, Joel D. Moore et al. · Organic Letters · 2005 · 53 citations · Full text

Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits

Mark E. Schnute, Matthew D. McReynolds, Jeffrey Carroll et al. · Journal of Medicinal Chemistry · 2017 · 52 citations · Full text

A Concise Route to Structurally Diverse DMP 323 Analogues via Highly Functionalized 1,4-Diamines

Matthew D. McReynolds, Kevin T. Sprott, Paul R. Hanson · Organic Letters · 2002 · 35 citations

Rows per page

1–5 of 7